Total Payments
$46,709
2024 Payments
$1,035
Companies
27
Transactions
271
Medicare Patients
3,158
Medicare Billing
$653,890
Payment Breakdown by Category
Other$29,942 (64.1%)
Consulting$11,516 (24.7%)
Food & Beverage$5,223 (11.2%)
Education$27.29 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,943 | 18 | 64.1% |
| Consulting Fee | $11,516 | 8 | 24.7% |
| Food and Beverage | $5,223 | 242 | 11.2% |
| Education | $27.29 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vapotherm Inc | $11,525 | 14 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $9,982 | 17 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $9,933 | 13 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $6,531 | 16 | $0 (2023) |
| Mylan Specialty L.P. | $4,668 | 9 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,468 | 77 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $559.52 | 30 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $383.32 | 15 | $0 (2024) |
| AbbVie Inc. | $320.16 | 12 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $242.65 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,035 | 43 | GlaxoSmithKline, LLC. ($568.45) |
| 2023 | $9,452 | 72 | Vapotherm Inc ($8,148) |
| 2022 | $3,908 | 38 | Vapotherm Inc ($3,274) |
| 2021 | $513.85 | 22 | Actelion Pharmaceuticals US, Inc. ($167.29) |
| 2020 | $2,771 | 11 | Mylan Specialty L.P. ($2,659) |
| 2019 | $2,384 | 24 | Mylan Specialty L.P. ($1,965) |
| 2018 | $15,696 | 36 | Sunovion Pharmaceuticals Inc. ($8,794) |
| 2017 | $10,948 | 25 | Janssen Pharmaceuticals, Inc ($9,534) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $32.29 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Respiratory | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Respiratory | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: RESPIRATORY | ||||||
| 05/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $36.64 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 767 | 1,344 | $581,505 | $136,443 |
| 2022 | 13 | 833 | 1,589 | $585,116 | $153,535 |
| 2021 | 14 | 791 | 1,557 | $604,188 | $162,807 |
| 2020 | 11 | 767 | 1,878 | $468,501 | $201,105 |
Total Patients
3,158
Total Services
6,368
Medicare Billing
$653,890
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 75 | 176 | $198,901 | $32,639 | 16.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 159 | 416 | $97,078 | $27,637 | 28.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 101 | 222 | $76,248 | $22,658 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 198 | $66,726 | $21,088 | 31.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 115 | 117 | $81,819 | $17,004 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 74 | $16,872 | $5,258 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $20,368 | $4,736 | 23.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $10,697 | $2,633 | 24.6% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 12 | 16 | $8,519 | $1,703 | 20.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,820 | $726.94 | 25.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 15 | 15 | $600.00 | $149.40 | 24.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 15 | 15 | $465.00 | $112.65 | 24.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 14 | 14 | $392.00 | $97.58 | 24.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 93 | 216 | $157,896 | $39,594 | 25.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 141 | 402 | $132,258 | $34,178 | 25.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 151 | 425 | $96,900 | $25,586 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 192 | $64,704 | $20,030 | 31.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 91 | 97 | $63,244 | $15,942 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $31,624 | $7,919 | 25.0% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 18 | 34 | $17,170 | $3,976 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 43 | $9,804 | $3,235 | 33.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $8,004 | $2,229 | 27.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 31 | 31 | $1,240 | $316.05 | 25.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 32 | 32 | $992.00 | $246.00 | 24.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 20 | 20 | $860.00 | $176.53 | 20.5% |
About Dr. Ari Ciment, MD
Dr. Ari Ciment, MD is a Pulmonary Disease healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932261542.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ari Ciment, MD has received a total of $46,709 in payments from pharmaceutical and medical device companies, with $1,035 received in 2024. These payments were reported across 271 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,943).
As a Medicare-enrolled provider, Ciment has provided services to 3,158 Medicare beneficiaries, totaling 6,368 services with total Medicare billing of $653,890. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Miami Beach, FL
- Active Since 12/14/2006
- Last Updated 05/06/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1932261542
Products in Payments
- VAPOTHERM (Device) $11,496
- XARELTO (Drug) $9,933
- Utibron (Drug) $6,686
- Yupelri (Drug) $4,623
- SPIRIVA RESPIMAT (Drug) $2,372
- LONHALA MAGNAIR (Drug) $2,128
- TRELEGY ELLIPTA (Drug) $676.43
- NUCALA (Biological) $398.25
- UPTRAVI (Drug) $366.86
- AVYCAZ (Drug) $357.54
- FASENRA (Biological) $223.17
- GLASSIA (Biological) $219.37
- Prolastin-C Liquid (Biological) $183.99
- AREXVY (Drug) $169.03
- DUPIXENT (Biological) $168.67
- TEZSPIRE (Biological) $131.32
- OFEV (Drug) $124.62
- Adempas (Drug) $84.94
- AIRSUPRA (Drug) $75.55
- ACTHAR (Biological) $75.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Miami Beach
Dr. Hernando Garcia, M.d, M.D
Pulmonary Disease — Payments: $34,304
Pulmonary Disease $34,304
Joseph Paprota, M.d, M.D
Pulmonary Disease — Payments: $3,825
Pulmonary Disease $3,825
Dr. Lawrence Ciment, M.d, M.D
Pulmonary Disease — Payments: $1,614
Pulmonary Disease $1,614
Dr. Robert Galbut, M.d, M.D
Pulmonary Disease — Payments: $1,322
Pulmonary Disease $1,322
Dr. Jerry Capote, M.d, M.D
Pulmonary Disease — Payments: $648.40
Pulmonary Disease $648.40
Adolfo Alvarez, Do, DO
Pulmonary Disease — Payments: $580.37
Pulmonary Disease $580.37